Cargando…

Targeting Microglial Population Dynamics in Alzheimer’s Disease: Are We Ready for a Potential Impact on Immune Function?

Alzheimer’s disease (AD) is the most common form of dementia, affecting two-thirds of people with dementia in the world. To date, no disease-modifying treatments are available to stop or delay the progression of AD. This chronic neurodegenerative disease is dominated by a strong innate immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Estebane, Maria, Gomez-Nicola, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289918/
https://www.ncbi.nlm.nih.gov/pubmed/32581720
http://dx.doi.org/10.3389/fncel.2020.00149